Healthpeak Properties, Inc. DOC SPX
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical 530 properties; (ii) Lab 139 properties; (iii) CCRC 15 properties; and (iv) Other non-reportable 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Compounding revenue at 11.0% over 5 years.
- Attractive dividend yield of 6.37%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 59.8.
- Earnings shrank at -47.8% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Real Estate).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DOC Healthpeak Properties, Inc. SPX | 19.15 | 59.84 | $13.20B | 6.37% | 3.18% | 2.80% | 11.05% | -47.76% |
| 2 | WELL Welltower Inc. SPX | 205.33 | 99.19 | $144.95B | 1.44% | 0.26% | 3.67% | 22.69% | 87.90% |
| 3 | PLD Prologis, Inc. SPX | 143.47 | 36.14 | $133.76B | 2.98% | 4.94% | 6.84% | 13.74% | -0.36% |
| 4 | EQIX Equinix, Inc. SPX | 1,068.04 | 74.07 | $105.33B | 1.84% | 5.61% | 10.06% | 8.27% | 24.18% |
| 5 | AMT American Tower Corporation SPX | 186.96 | 30.11 | $87.10B | 3.73% | 7.82% | 29.95% | 3.34% | 12.73% |
| 6 | SPG Simon Property Group, Inc. SPX | 204.91 | 14.25 | $77.86B | 4.29% | 17.44% | 113.59% | 6.35% | 29.32% |
| 7 | DLR Digital Realty Trust, Inc. SPX | 190.00 | 50.53 | $67.96B | 2.57% | 3.99% | 5.69% | 9.22% | 51.32% |
| 8 | O Realty Income Corporation SPX | 61.28 | 50.23 | $57.14B | 5.30% | 3.27% | 2.83% | 19.80% | 6.78% |
| 9 | PSA Public Storage SPX | 303.69 | 31.34 | $53.31B | 3.95% | 10.69% | 20.18% | 4.88% | -25.69% |
Quarterly Results
Figures in USD.
| Metric | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 142.81M | 136.77M | 137.36M | - | 126.69M | 177.77M | 213.04M | - | 91.78M | 113.93M | 115.03M | - | 116.13M | 117.31M | 119.02M | - | 121.56M | 125.36M | 122.14M | - | 127.08M | 130.18M | 133.81M | 138.78M | 140.89M | - | - | 702.89M | 694.35M | 705.87M | 719.40M | 752.95M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 273.14M | 276.18M | 291.92M | 287.85M | 323.86M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 429.75M | 418.17M | 413.95M | 431.55M | 429.09M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 294.66M | 286.68M | 282.22M | 285.71M | 314.32M |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 135.08M | 131.49M | 131.73M | 145.84M | 114.77M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 395.53M | 390.85M | 404.34M | 467.84M | 572.67M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 72.69M | 75.06M | 76.78M | 80.64M | 87.29M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 54.29M | 39.65M | 65.24M | 125.11M | 195.65M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.08M | 2.38M | -1.21M | 6.03M | 254.00K |
| Net Income | 116.12M | 301.72M | 151.25M | 58.66M | 461.14M | 19.38M | -7.66M | -58.70M | 40.23M | 89.94M | 99.37M | 831.55M | 61.47M | -13.60M | -45.86M | 43.52M | 279.08M | 51.51M | -63.42M | 146.39M | 145.79M | 276.28M | 54.71M | 28.76M | 71.61M | 68.34M | 353.97M | 6.53M | 118.95M | 51.90M | 64.21M | 6.68M | 146.05M | - | - | 42.83M | 31.67M | -117.12M | 113.97M | 193.63M |
| Diluted EPS | 0.25 | 0.64 | 0.32 | 0.12 | 0.97 | 0.04 | -0.02 | -0.13 | 0.08 | 0.19 | 0.21 | 1.73 | 0.13 | -0.03 | -0.09 | 0.09 | 0.54 | 0.09 | -0.12 | - | 0.27 | 0.51 | 0.10 | - | 0.13 | 0.13 | 0.65 | - | 0.22 | 0.09 | 0.12 | 0.01 | 0.21 | - | - | 0.06 | 0.05 | -0.17 | 0.16 | 0.28 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 524.27M | 144.22M | 144.33M | 436.49M | - | 2.06B | 2.18B | 2.70B | 2.82B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 862.99M | 902.06M | 1.07B | 1.13B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.20B | 1.28B | 1.63B | 1.69B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 841.60M | 845.03M | 1.15B | 1.15B |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 356.58M | 433.91M | 471.22M | 544.13M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.39B | 1.27B | 1.61B | 1.65B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 172.94M | 200.33M | 280.43M | 305.18M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 507.13M | 314.94M | 273.17M | 284.29M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -4.42M | -9.62M | 4.35M | 9.28M |
| Net Income | - | 448.50M | 131.69M | 330.71M | 538.89M | 832.54M | 970.84M | 922.23M | -559.24M | 627.75M | 414.17M | 1.06B | 45.53M | 413.56M | - | 500.45M | 306.01M | 243.14M | 71.35M |
| Diluted EPS | 2.70 | 1.79 | 0.40 | 1.00 | 1.29 | 1.90 | 2.13 | 2.00 | -1.21 | 1.34 | 0.88 | 2.24 | 0.09 | 0.77 | - | 0.92 | 0.56 | 0.36 | 0.10 |
Compounded Sales Growth
| 5 Years: | 11.05% |
| 1 Year: | 7.10% |
Compounded Profit Growth
| 5 Years: | -47.76% |
| 1 Year: | 363.90% |
Stock Price Performance
| 1 Year: | +17.94% |
| 6 Months: | +9.56% |
| 3 Months: | +10.19% |
| 1 Month: | +20.40% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 11.85B | 12.21B | 13.33B | 17.41B | 19.92B | 20.08B | 21.33B | 21.45B | 15.76B | 14.09B | 12.72B | 14.03B | 15.92B | - | 15.77B | 15.70B | 19.94B | 20.34B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 604.97M | 561.28M | 924.87M | 1.30B |
| Cash & Equivalents | 58.41M | 96.27M | 57.56M | 112.26M | 1.04B | 33.51M | 247.67M | 300.56M | 181.92M | 340.44M | 94.73M | 55.31M | 53.98M | 80.40M | 44.23M | - | 72.03M | 117.64M | 119.82M | 467.46M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 53.44M | 55.82M | 76.81M | 78.33M |
| Total Liabilities | - | - | 6.44B | 6.25B | 5.19B | 8.19B | 9.16B | 9.14B | 10.33B | 11.70B | 9.82B | 8.49B | 6.21B | 7.37B | 8.57B | - | 8.48B | 8.77B | 10.88B | 12.03B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.77B | 1.38B | 875.34M | 1.81B |
| Long Term Debt | - | - | - | - | - | 7.63B | 8.61B | 8.59B | 9.66B | 10.97B | 9.10B | 7.79B | 5.48B | 6.30B | 6.62B | - | 5.50B | 6.16B | 8.57B | 8.77B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.71B | 7.08B | 9.02B | 10.14B |
| Total Equity | - | - | 5.20B | 5.78B | 7.96B | 9.03B | 10.55B | 10.72B | 10.74B | 9.34B | 5.55B | 5.30B | 5.94B | 6.09B | 6.73B | - | 6.65B | 6.35B | 8.40B | 7.50B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 546.64M | 547.16M | 699.49M | 695.04M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 453.05M | 568.70M | 515.63M | 580.50M | 724.16M | 1.03B | 1.15B | 1.25B | 1.22B | 1.21B | 847.04M | 848.71M | 846.07M | 758.43M | - | 900.26M | 956.24M | 1.07B | 1.25B |
| Investing Cash Flow | -2.89B | 427.33M | -61.41M | -430.93M | -4.58B | -2.31B | -196.65M | -1.51B | -1.66B | -428.97M | 1.25B | 1.83B | -1.45B | -1.01B | - | -876.34M | -576.75M | -113.80M | -1.03B |
| Financing Cash Flow | 2.47B | -1.03B | -399.53M | 774.87M | 2.85B | 1.49B | -900.42M | 144.80M | 614.09M | -1.05B | -2.15B | -2.62B | 647.27M | 246.45M | - | -116.53M | -337.30M | -941.42M | 136.11M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 900.26M | 956.24M | 1.07B | 1.25B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -92.61M | 42.19M | 15.28M | 353.40M |
| Share Buybacks | - | - | - | - | - | - | - | 12.70M | 8.74M | 8.69M | 4.79M | 3.43M | 5.04M | 10.53M | 12.84M | 67.84M | 6.52M | 190.69M | 97.14M |
| Dividends Paid | 393.57M | 457.64M | 517.07M | 590.74M | 787.69M | 865.31M | 956.68M | 1.00B | 1.05B | 979.54M | 694.96M | 696.91M | 720.12M | 787.07M | 650.08M | 648.05M | 657.02M | 794.78M | 849.10M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 58.1% | 58.6% | 60.2% | 60.0% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.3% | 19.9% | 17.4% | 19.3% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | 79.0% | 735.8% | 31.5% | 94.7% | - | 24.3% | 14.0% | 9.0% | 2.5% |
| ROE % | - | 8.6% | 2.3% | 4.2% | 6.0% | 7.9% | 9.1% | 8.6% | -6.0% | 11.3% | 7.8% | 17.9% | 0.7% | 6.1% | - | 7.5% | 4.8% | 2.9% | 1.0% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.5% | 3.0% | 2.5% | 2.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 10.64% | 73.36M | $1.40B |
| 2 | Vanguard Portfolio Management LLC | 8.43% | 58.13M | $1.11B |
| 3 | State Street Corporation | 7.03% | 48.50M | $928.79M |
| 4 | Vanguard Capital Management LLC | 6.56% | 45.22M | $865.94M |
| 5 | JPMORGAN CHASE & CO | 6.49% | 44.73M | $856.61M |
| 6 | Fuller & Thaler Asset Management Inc. | 4.24% | 29.20M | $559.21M |
| 7 | Geode Capital Management, LLC | 3.54% | 24.40M | $467.28M |
| 8 | Invesco Ltd. | 3.51% | 24.17M | $462.81M |
| 9 | Principal Financial Group, Inc. | 2.72% | 18.77M | $359.36M |
| 10 | Bank Of New York Mellon Corporation | 2.24% | 15.46M | $295.99M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DOC